Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19
Clinical trial NCT04928430 · TERMINATED
Trial details
- NCT number
- NCT04928430
- Sponsor
- Xenothera SAS
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2022-11-28
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.